457 related articles for article (PubMed ID: 30420859)
1. A Low Frequency of IL-17-Producing CD8
Perdomo-Celis F; Feria MG; Taborda NA; Rugeles MT
Front Immunol; 2018; 9():2502. PubMed ID: 30420859
[TBL] [Abstract][Full Text] [Related]
2. An altered cytotoxic program of CD8+ T-cells in HIV-infected patients despite HAART-induced viral suppression.
Perdomo-Celis F; Velilla PA; Taborda NA; Rugeles MT
PLoS One; 2019; 14(1):e0210540. PubMed ID: 30625227
[TBL] [Abstract][Full Text] [Related]
3. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
4. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
[TBL] [Abstract][Full Text] [Related]
5. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.
Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA
J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220
[TBL] [Abstract][Full Text] [Related]
7. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
8. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
Front Immunol; 2019; 10():289. PubMed ID: 30846990
[No Abstract] [Full Text] [Related]
9. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
10. CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients--reversal by highly active anti-retroviral therapy (HAART).
Colle JH; Moreau JL; Fontanet A; Lambotte O; Joussemet M; Delfraissy JF; Thèze J
Clin Exp Immunol; 2006 Mar; 143(3):398-403. PubMed ID: 16487237
[TBL] [Abstract][Full Text] [Related]
11. Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
Beran O; Holub M; Spála J; Kalanin J; Stanková M
Acta Virol; 2003; 47(2):121-4. PubMed ID: 14524479
[TBL] [Abstract][Full Text] [Related]
12. [The correlation of HIV-1 viral load to expression of CD8+ T lymphocyte activators CD38 and HLA-DR].
Han Y; Qiu ZF; Li TS; Xie J; Zuo LY; Kuang JQ; Wang AX
Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):459-62. PubMed ID: 16831321
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution in HIV+ subjects on lopinavir/ritonavir-based HAART according to the severity of pre-therapy CD4+.
Marchetti G; Merlini E; Sinigaglia E; Iannotti N; Bai F; Savoldi A; Tincati C; Carpani G; Bini T; Arminio Monforte A
Curr HIV Res; 2012 Oct; 10(7):597-605. PubMed ID: 22716104
[TBL] [Abstract][Full Text] [Related]
14. Increase in frequencies of circulating Th-17 cells correlates with microbial translocation, immune activation and exhaustion in HIV-1 infected patients with poor CD4 T-cell reconstitution.
Valiathan R; Asthana D
Immunobiology; 2016 May; 221(5):670-8. PubMed ID: 26817581
[TBL] [Abstract][Full Text] [Related]
15. Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection.
Clutton G; Yang H; Hancock G; Sande N; Holloway C; Angus B; von Delft A; Barnes E; Borrow P; Pellegrino P; Williams I; McMichael A; Dorrell L
Eur J Immunol; 2013 Nov; 43(11):2875-85. PubMed ID: 23897063
[TBL] [Abstract][Full Text] [Related]
16. Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
Najafi Fard S; Schietroma I; Corano Scheri G; Giustini N; Serafino S; Cavallari EN; Pinacchio C; De Girolamo G; Ceccarelli G; Scagnolari C; Vullo V; d'Ettorre G
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):319-329. PubMed ID: 29279268
[TBL] [Abstract][Full Text] [Related]
17. Potential role for HIV-specific CD38-/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers.
Hua S; Lécuroux C; Sáez-Cirión A; Pancino G; Girault I; Versmisse P; Boufassa F; Taulera O; Sinet M; Lambotte O; Venet A
PLoS One; 2014; 9(7):e101920. PubMed ID: 25000587
[TBL] [Abstract][Full Text] [Related]
18. Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
Massanella M; Negredo E; Puig J; Puertas MC; Buzón MJ; Pérez-Álvarez N; Carrillo J; Clotet B; Martínez-Picado J; Blanco J
AIDS; 2012 Nov; 26(18):2285-93. PubMed ID: 23018435
[TBL] [Abstract][Full Text] [Related]
19. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
